As of January 2026 Immunome has a market cap of ยฃ1.84 Billion. This makes Immunome the world's 4377th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 18th, 2026 the market cap of Immunome was reported to be: